ストックスクリーナーアプリを入手
1.79
7.25%
-0.14
アフターアワーズ：
1.83
0.04
+2.23%
Century Therapeutics Inc (IPSC) 最新ニュース
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Expands By 320.2% - MarketBeat
Bull Run: Will Century Therapeutics Inc stock go up in YEARShort Setup & Target Return Focused Stock Picks - baoquankhu1.vn
Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race - Seeking Alpha
Century Therapeutics, Inc. (NASDAQ:IPSC) Receives $3.80 Average PT from Brokerages - Defense World
Century Therapeutics (IPSC) Price Target Increased by 10.75% to 4.20 - Nasdaq
Valuation Update: Is Oramed Pharmaceuticals Inc stock overvalued or fairly pricedMarket Growth Review & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Chart Watch: Is Century Therapeutics Inc stock undervalued right nowSell Signal & Technical Confirmation Alerts - baoquankhu1.vn
Century Therapeutics (NASDAQ:IPSC) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Century Therapeutics (NASDAQ:IPSC) Lowered to “Sell” Rating by Wall Street Zen - Defense World
Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND Submission - Finviz
Risk Analysis: Will Century Therapeutics Inc benefit from current market trendsDollar Strength & Smart Money Movement Tracker - baoquankhu1.vn
Piper Sandler highlights Century Therapeutics (IPSC) cash runway through 2029, upcoming IND submission - MSN
7 Best Fast Growing Penny Stocks to Buy According to Analysts - Insider Monkey
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Grows By 148.0% - MarketBeat
Why retail investors favor Century Therapeutics Inc. stockWeekly Trading Summary & High Accuracy Swing Entry Alerts - mfd.ru
Volume Report: Whats the RSI of Century Therapeutics Inc stock2025 Buyback Activity & Risk Managed Trade Strategies - baoquankhu1.vn
Century Therapeutics (IPSC) upgraded to strong buy: Here's what you should know - MSN
Century Therapeutics (NASDAQ:IPSC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split - TipRanks
How sensitive is Century Therapeutics Inc to inflationQuarterly Portfolio Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Deep Track Capital, LP's Strategic Acquisition of Century Therap - GuruFocus
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler - Investing.com India
Will Century Therapeutics Inc. stock deliver long term returnsTrend Reversal & Reliable Price Action Trade Plans - bollywoodhelpline.com
Big Money Moves: Will Century Therapeutics Inc benefit from seasonalityJuly 2025 Trends & Weekly Breakout Watchlists - baoquankhu1.vn
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Rises By 32.1% - MarketBeat
Short Squeeze: Whats the RSI of Century Therapeutics Inc stockVolume Spike & Real-Time Buy Signal Alerts - baoquankhu1.vn
Brokerages Set Century Therapeutics, Inc. (NASDAQ:IPSC) PT at $3.40 - Defense World
Century Therapeutics, Inc Updates on Pipeline and Clinical Progress - TradingView — Track All Markets
Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Finance Watch: Aktis Tests 2026 IPO Waters With Year’s First Offering, Raising $318m - Citeline News & Insights
Century Therapeutics (NASDAQ:IPSC) Upgraded at Zacks Research - Defense World
Century Therapeutics: Is This Stem Cell Stock Taking Root In 2026? - RTTNews
Is Century Therapeutics Inc. stock supported by strong cash flowsWeekly Trading Summary & Free Technical Pattern Based Buy Signals - Улправда
Can Century Therapeutics Inc. stock outperform in 2025 bull marketMarket Performance Summary & Expert Verified Stock Movement Alerts - ulpravda.ru
Century Therapeutics Inc. (IPSC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How strong is Century Therapeutics Inc. stock revenue growthOil Prices & Stepwise Swing Trade Plans - ulpravda.ru
Can Century Therapeutics Inc. stock surprise with earnings upsidePortfolio Return Summary & AI Forecasted Stock Moves - Улправда
Century Therapeutics Inc.: Is an Upswing Approaching? - StocksToTrade
Century Therapeutics wins $135M private placement (IPSC:NASDAQ) - Seeking Alpha
Will Century Therapeutics Inc. stock deliver better than expected guidanceEarnings Growth Summary & Trade Opportunity Analysis Reports - Улправда
Can Century Therapeutics Inc. stock reach $100 price target2025 Geopolitical Influence & Safe Swing Trade Setups - ulpravda.ru
Century Therapeutics stock price target lowered to $6.60 at Clear Street - Investing.com Canada
Is Century Therapeutics Inc. stock attractive after correctionJuly 2025 PreEarnings & Consistent Growth Stock Picks - Улправда
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aug Swings: What sentiment indicators say about Century Therapeutics Inc. stockTrend Reversal & Daily Chart Pattern Signals - Улправда
Why Century Therapeutics Inc. stock is rated strong buyTrade Entry Report & Weekly Market Pulse Updates - Улправда
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes - Investing News Network
Century Therapeutics: New Leadership Sparks Interest - timothysykes.com
Layoff Watch: Is Century Therapeutics Inc. stock attractive for income investors2025 Risk Factors & Verified Short-Term Plans - ulpravda.ru
Century Therapeutics secures $135 million in private placement By Investing.com - Investing.com India
Century Therapeutics secures oversubscribed $135 million private placement financing to support lead program, CNTY-813 - marketscreener.com
Century Therapeutics secures $135 million in private placement - Investing.com
Century Therapeutics Signs Multiple Financing Agreements - TradingView — Track All Markets
[8-K] Century Therapeutics, Inc. Reports Material Event | IPSC SEC FilingForm 8-K - Stock Titan
2.09%
2.01%
大文字化:
|
ボリューム (24 時間):